G867-0230 Screening compound: 1-{3-benzyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl}-4-(4-methoxy-3-methylbenzenesulfonyl)piperazine

G867-0230 Screening compound: 1-{3-benzyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl}-4-(4-methoxy-3-methylbenzenesulfonyl)piperazine
G867-0230 Screening compound: 1-{3-benzyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl}-4-(4-methoxy-3-methylbenzenesulfonyl)piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound G867-0230
1-{3-benzyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl}-4-(4-methoxy-3-methylbenzenesulfonyl)piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G867-0230

Molecular Formula

C23H25N7O3S (C23 H25 N7 O3 S)

Compound Name

1-{3-benzyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl}-4-(4-methoxy-3-methylbenzenesulfonyl)piperazine

IUPAC name

1-{3-benzyl-3H-[123]triazolo[45-d]pyrimidin-7-yl}-4-(4-methoxy-3-methylbenzenesulfonyl)piperazine

SMILES

Cc(cc(cc1)S(N(CC2)CCN2c2ncnc3c2nnn3Cc2ccccc2)(=O)=O)c1OC

InChI

InChI=1S/C23H25N7O3S/c1-17-14-19(8-9-20(17)33-2)34(31,32)29-12-10-28(11-13-29)22-21-23(25-16-24-22)30(27-26-21)15-18-6-4-3-5-7-18/h3-9,14,16H,10-13,15H2,1-2H3

InChI Key

SKOZLJIQWMPRTK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD08344849

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

479.56

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.253

Distribution Coefficient, logD

3.253

Water Solubility, LogSw

-3.39

Polar Surface Area

89.638

Acid Dissociation Constant (pKa)

19.60

Base Dissociation Constant (pKb)

3.76

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.40

G867-0230 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Angiogenesis library (14822 compounds)

C-Met Library (15277 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G867-0230 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G867-0230?
Check Price and Availability of G867-0230, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G867-0230 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G867-0230
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G867-0230
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G867-0230 available by request